Radiopharm Theranostics Limited American Depositary Shares (RADX) — Financial Flexibility Index
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Financial Flexibility Index of -0.22x as of December 2024. Free cash flow of $-8.74 Million (operating CF $-8.74 Million minus capex $0.00) represents 0% of total liabilities ($40.45 Million). Also explore RADX net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Radiopharm Theranostics Limited American Depositary Shares Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Radiopharm Theranostics Limited American Depositary Shares across 4 annual periods. Check RADX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Radiopharm Theranostics Limited American Depositary Shares (2022–2025)
Year-by-year free cash flow to debt coverage for Radiopharm Theranostics Limited American Depositary Shares. For the full company profile including market capitalisation, see Radiopharm Theranostics Limited American market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.84x | $-36.65 Million | $-36.65 Million | $43.61 Million | ▼ -63.4% |
| 2024 | -0.51x | $-22.98 Million | $-22.98 Million | $44.68 Million | ▲ +30.3% |
| 2023 | -0.74x | $-21.67 Million | $-23.20 Million | $29.37 Million | ▼ -181.8% |
| 2022 | 0.90x | $18.42 Million | $-9.92 Million | $20.42 Million | — |